Study of some polyoxometallates of Keggin's type as potential antitumour agents

Jugoslovenska Medicinska Biohemija

Volumn 23, Issue 1, 2004, Pages 25-30

  Holclajtner Antunović, Ivanka ^a,d   Kuntić, Vesna ^b,e   Juranić, Zorica ^c   Filipović, Ivana ^c   Mioč, Ubavka ^a,d   Stanojković, Tatjana ^c   Žižak, Željko ^c  

^a Vinca Instititute of Nucl Sci   (Yugoslavia)

^b UNIVERSITY OF BELGRADE   (Serbia)

^c INSTITUTE FOR ONCOLOGY AND RADIOLOGY OF SERBIA   (Serbia)

^d Fakultet za Fizi ku Hemiju   (Yugoslavia)

^e Farmaceutski Fakultet   (Yugoslavia)

Author keywords

Antitumour effect; HeLa cells; Polyoxometallates

Indexed keywords

12 MOLYBDOPHOSPHORIC ACID; 12 TUNGSTOPHOSPHORIC ACID; ANTINEOPLASTIC AGENT; MAGNESIUM DERIVATIVE; POLYOXOMETALLATE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CALCULATION; CELL SURVIVAL; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG MECHANISM; HELA CELL; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; MONONUCLEAR CELL;

EID: 1842584455     PISSN: 03543447     EISSN: None     Source Type: Journal    
DOI: 10.2298/JMH0401025H     Document Type: Article

References (16)

1. Rosenberg B, Van Camp L, Trosco IE. Platinum compounds: New class of potent antitumour agents. Nature 1969; 222: 385-6.
2. Katsaros N, Anagnostopoulou A. Rhodium and its compunds as potential agents in cancer treatment. Crit Rev Oncol/Hematol 2002; 42: 297-308.
3. Pope, MT. Heteropoly and Isopoly Oxometalates: Springer-Verlag, Berlin 1983.
4. Rhule TJ, Hill LC, Judd AD. Polyoxometalates in Medicine. Chem Rev 1998; 98: 327-57.
5. Raynaud M, Chermann JC, Plata F, Jasmin C, Mathe G C R Acad Sci., Ser: D 1971; 272: 347-8.
6. Inouye Y, Tokutake Y. Suppresive Effect of POMs of HIV Type 1 in Vitro. Chem Pharm Bullet 1992; 40: 805-7.
7. Yamase T, Tomita K, Sato Y, Fujita H. Antitumour and Antivirus Activities of Certain Polyoxometalates, Polymer in Medicine: Biomedical and Pharmaceutical Applications. Technomic Pub. Company Inc., Lancaster, 1992. Chapter 13, 187-212.
8. Seelig MS. Magnesium (and trace substance) deficiencies in the pathogenesis of cancer. Biol Tr Elem Res 1979; 1: 273-97.
9. Wacker WEC. Magnesium and Man. Harvard Univ. Press, Cambridge, MA, 1980.
10. Walker GM. Magnesium as the fundamental regulator of the cell cycle. Magnesium 1982; 2: 1-16.
11. Walker GM. Magnesium and cell cycle control: an update. Magnesium 1986; 5: 9-23.
12. Duffus JH, Walker GM. Magnesium in mitosis and the cell cycle. In Magnesium in Cellular Processes and Medicine, (from 4th Intl Mg Sympos, Blacksburg, W. Virginia, 1985 Eds B.M. Altura, J. Durlach, M.S. Seelig, Publ. S. Karger AG, Basel, Switzerland, 1987; 131 41.
13. Mioč, U, Colomban Ph, Novak A. Infrared and Raman study of some heteropolyacid hydrates. J Mol Struct 1990; 218: 123 8.
14. 26-type bronzes. J Mat Sci 1994; 29: 3705 18.
15. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: application toproliferation and cytotoxicity assays J Immunol Meth 1983; 65: 55 63.
16. Ohno M, Abe TJ. Rapid colorimetric assay for the quantification of leukemia inhibitory factor (LIF) and interleukin-6 (IL-6). J Immunol Meth 1991; 145: 199 203.